Comparison of Long-Term Outcomes of Trabeculectomy with Polyvinylpyrrolidone Collagen Versus Trabeculectomy with Mitomycin in Primary Open Angle Glaucoma. 36-Month Follow-up | ASCRS
Poster
Comparison of Long-Term Outcomes of Trabeculectomy with Polyvinylpyrrolidone Collagen Versus Trabeculectomy with Mitomycin in Primary Open Angle Glaucoma. 36-Month Follow-up
May 2019
Meeting: 2019 Annual Meeting
Authors: Daniela Alvarez-Ascencio, MD ; Marla Alvarez-Padilla, MD; Armando Castillejos-Chevez, MD; Felix Gil-Carrasco, MD; Jesus Jimenez-Roman, MD; Paulina Tolosa-Tort, MD
Poster ID: 54588
You must be logged in to view this content

This resource is only available for ASCRS Members. Please log in using the teal "Login" button in the top right-hand corner to log in.

Poster Abstract

Purpose
Describe and compare the effects of intraoperative application of Polyvinylpyrrolidone Collagen(PVP) versus Mitomycin C(MMC) in IOP and number of medications reduction over a 36-month follow-up in patients with primary open angle glaucoma(POAG) undergoing trabeculectomy.
Methods
Prospective,randomized,comparative study.Twenty-eight eyes of 28 patients with POAG underwent primary trabeculectomy and were randomized to PVP or MMC and completed a 36-month follow-up.The main outcome measures were IOP and number of glaucoma medications.Multivariate longitudinal analysis was performed by fitting a linear trend model adjusting for baseline response for the IOP outcome and a log-linear regression model with within-subject associations for the number of hypotensive medications outcome.Sensitivity analysis was performed to assess lower and higher order polynomial trends over time in IOP.
Results
Mean IOP reduction was 7.62mmHg(3.05,12.18)in the MMC group and 8.15 mmHg(-0.64,16.95)in the PVP group,mean percentage IOP reduction was 37.09%(15.93, 58.17)and 36.08%(5.16, 67.20)respectively.Mean change in number of medications was -0.92medications(-3.38,+1.54))and -1 medication(-3.12,+1.12)respectively.Both groups had a statistically significant decline in mean IOP(p<0.001),there was no discernible difference between the groups(p=0.5975).Sensitivity analysis showed that a linear trend model is adequate to describe the IOP reduction over the follow-up.Both groups had a significant change in the number of hypotensive medications(p<0.05)with no difference between groups(p=0.2917).
Conclusion
The use of PVP during trabeculectomy achieves and maintains a significant IOP reduction and decreases the number of glaucoma medications.Secondary outcome measures showed a lower incidence of adverse events in the PVP group. We can conclude than PVP collagen can be used as an antifibrotic agent in trabeculectomy with comparable outcomes to MMC and potentially less adverse events.

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.